Target intelligence / Profile preview

Innate immune pattern-recognition receptors (PRRs)

Target
PRRs
Molecular classification
Receptor, Enzyme, Other
01

Overview

Innate immune pattern-recognition receptors (PRRs) are a diverse class of germline-encoded sensors primarily expressed on antigen-presenting cells (APCs) such as dendritic cells and macrophages (Janeway and Medzhitov, 2002, Annu Rev Immunol). These receptors are specialized to detect pathogen-associated molecular patterns (PAMPs) from microbes and damage-associated molecular patterns (DAMPs) from host cells (Iwasaki and Medzhitov, 2015, Nat Immunol). Major families include Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), and the cGAS-STING pathway (Thompson et al., 2011, Viruses). Activation of these pathways triggers signaling cascades that lead to the production of pro-inflammatory cytokines and type I interferons, which are essential for bridging innate and adaptive immunity (Kawai and Akira, 2010, Nat Immunol). In therapeutic contexts, PRR agonists like imiquimod and monophosphoryl lipid A are used as vaccine adjuvants or cancer immunotherapies to stimulate robust T-cell responses (Kaczanowska et al., 2013, Front Immunol). Conversely, the overactivation or dysregulation of these pathways is implicated in chronic inflammatory and autoimmune diseases, making them targets for inhibitory therapies (O'Neill et al., 2013, Nat Rev Immunol).

Other names
Pattern recognition receptorsPRRsInnate immune sensorsPAMP receptorsDAMP receptorsInnate immune pattern-recognition pathways
02

Mechanism of action

Agonism of specific receptors (e.g., TLRs, STING) to enhance immune activation or antagonism to suppress pathological inflammation (Kaczanowska et al., 2013, Front Immunol; O'Neill et al., 2013, Nat Rev Immunol).

03

Biological functions

Immune responseSignal transductionInflammationAntigen presentation
04

Disease associations

InfectionCancerInflammationAutoimmune disease
05

Safety considerations

Cytokine release syndromeSystemic inflammatory responseAutoimmunity inductionInjection site reactions
06

Interacting drugs

Imiquimod

7 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-α)Type I Interferon signatureCD80/CD86 expression

Beyond the preview

Go deeper on Innate immune pattern-recognition receptors (PRRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune pattern-recognition receptors (PRRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call